The Pro-inflammatory Cytokines, IL-1βand TNF-α, Inhibit Intestinal Alkaline Phosphatase Gene Expression
- 1 December 2006
- journal article
- research article
- Published by Mary Ann Liebert Inc in DNA and Cell Biology
- Vol. 25 (12), 684-695
- https://doi.org/10.1089/dna.2006.25.684
Abstract
High levels of the pro-inflammatory cytokines, interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), are present in the gut mucosa of patients suffering form various diseases, most notably inflammatory bowel diseases (IBD). Since the inflammatory milieu can cause important alterations in epithelial cell function, we examined the cytokine effects on the expression of the enterocyte differentiation marker, intestinal alkaline phosphatase (IAP), a protein that detoxifies bacterial lipopolysaccharides (LPS) and limits fat absorption. Sodium butyrate (NaBu), a short-chain fatty acid and histone deacetylase (HDAC) inhibitor, was used to induce IAP expression in HT-29 cells and the cells were also treated ± the cytokines. Northern blots confirmed IAP induction by NaBu, however, pretreatment (6 h) with either cytokine showed a dose-dependent inhibition of IAP expression. IAP Western analyses and alkaline phosphatase enzyme assays corroborated the Northern data and confirmed that the cytokines inhibit IAP induction. Transient transfections with a reporter plasmid carrying the human IAP promoter showed significant inhibition of NaBu-induced IAP gene activation by the cytokines (100 and 60% inhibition with IL-1β and TNF-α, respectively). Western analyses showed that NaBu induced H4 and H3 histone acetylation, and pretreatment with IL-1β or TNF-α did not change this global acetylation pattern. In contrast, chromatin immunoprecipitation showed that local histone acetylation of the IAP promoter region was specifically inhibited by either cytokine. We conclude that IL-1β and TNF-α inhibit NaBu-induced IAP gene expression, likely by blocking the histone acetylation within its promoter. Cytokine-mediated IAP gene silencing may have important implications for gut epithelial function in the setting of intestinal inflammatory conditions.Keywords
This publication has 70 references indexed in Scilit:
- Chromatin modifier enzymes, the histone code and cancerEuropean Journal Of Cancer, 2005
- Enterocyte differentiation marker intestinal alkaline phosphatase is a target gene of the gut-enriched Krüppel-like factorAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- Ethyl Pyruvate Ameliorates Intestinal Epithelial Barrier Dysfunction in Endotoxemic Mice and Immunostimulated Caco-2 Enterocytic MonolayersJournal of Pharmacology and Experimental Therapeutics, 2003
- Translating the Histone CodeScience, 2001
- Epithelial Barrier Defects in HT‐29/B6 Colonic Cell Monolayers Induced by Tumor Necrosis Factor‐αAnnals of the New York Academy of Sciences, 2000
- TNF-α modulates the differentiation induced by butyrate in the HT-29 human colon adenocarcinoma cell lineEuropean Journal Of Cancer, 2000
- Regulation of Sucrase-Isomaltase Gene Expression in Human Intestinal Epithelial Cells by Inflammatory CytokinesPublished by Elsevier BV ,1996
- Expression of Tumour Necrosis Factor-α, Interleukin-6, and Interleukin-2 mRNA in the Jejunum of Patients with Coeliac DiseaseScandinavian Journal of Gastroenterology, 1995
- Rectal irrigation with short-chain fatty acids for distal ulcerative colitisDigestive Diseases and Sciences, 1991
- Treatment of Diversion Colitis with Short-Chain-Fatty Acid IrrigationNew England Journal of Medicine, 1989